Apoptosis and Autophagy
Jurkat Apoptosis Cell Lysates (etoposide) |
イイネ！(0) | 
|
| CSTコード | 包装 | 希望納入価格 (円) |
国内在庫  2012年2月9日11時30分 現在 |
|
|---|---|---|---|---|
| #2043S | 100 μL | 22,000 | ログインすると国内在庫状況がご確認いただけます。
|
| 調製方法 | |
|---|---|
| 25 μM エトポシド処理 (5 hrs) と未処理のJurkat 細胞の溶解物。 |
| 貯法 | |
|---|---|
| -20℃ |
| MSDSはこちらから |
| バックグラウンド |
|---|
Apoptosis is a regulated physiological process leading to cell death. Caspases, a family of cysteine acid proteases, are central regulators of apoptosis. Initiator caspases (including 8, 9, 10 and 12) are closely coupled to proapoptotic signals. Once activated, these caspases cleave and activate downstream effector caspases (including 3, 6 and 7), which in turn cleave cytoskeletal and nuclear proteins like PARP, α-fodrin, DFF and lamin A, and induce apoptosis. Cytochrome c released from mitochondria is coupled to the activation of caspase-9, a key initiator caspase (1). Proapoptotic stimuli include the FasL, TNF-α, DNA damage and ER stress. Fas and TNFR activate caspases 8 and 10 (2), DNA damage leads to the activation of caspase-9 and ER stress leads to the calcium-mediated activation of caspase-12 (3). The inhibitor of apoptosis protein (IAP) family includes XIAP and survivin and functions by binding and inhibiting several caspases (4,5). Smac/Diablo, a mitochondrial protein, is released into the cytosol upon mitochondrial stress and competes with caspases for binding of IAPs. The interaction of Smac/Diablo with IAPs relieves the inhibitory effects of the IAPs on caspases (6).
- Baker, S.J. and Reddy, E.P. (1998) Oncogene 17, 3261-3270.
- Budihardjo, I. et al. (1999) Annu. Rev. Cell Dev. Biol. 15, 269-290.
- Nakagawa, T. et al. (2000) Nature 403, 98-103.
- Deveraux, Q. L. et al. (1998) EMBO J. 17, 2215-2223.
- Li, F. et al. (1998) Nature 396, 580-584.
- Du, C. et al. (2000) Cell 102, 33-42.
| 使用例 | |
|---|---|
| 製品をご使用いただいて研究を発表されましたら、ぜひお知らせください。 |
本製品は試験研究用です。